Treatment of Rhinitis Sicca Anterior with Ectoine Containing Nasal Spray

Table 3

Patients’ assessments of secondary symptom scores at days 3, 6, 9, and 12 following treatment start of study 1.

Symptoms	d3	d6	d9	d12	𝑃 value (d3 versus d12)
Nose bleeding	0.36 ± 0.85	0.46 ± 1.07	0.36 ± 0.85	0.30 ± 0.74	0.787
Pharyngitis	0.64 ± 1.77	0.62 ± 1.74	0.46 ± 1.20	0.42 ± 1.13	0.754
Exudate viscosity	3.36 ± 3.50	2.90 ± 3.03	2.38 ± 2.86	2.40 ± 2.93	0.108
Rhinorrhea	2.44 ± 2.16	2.10 ± 2.14	1.74 ± 1.88	1.42 ± 1.54	0.021
Cacosmia	0.60 ± 1.53	0.48 ± 1.31	0.42 ± 1.57	0.26 ± 0.69	0.388